Abstract
This paper examines the controversial topic of choosing our children’s genes through human germ-line manipulation otherwise known as Inheritable Genetic Modification (IGM) with current Assisted Reproductive Technologies (ARTs) and future Reproductive Genetic Biotechnologies (RGBs) such as genetic engineering. The purpose of the paper is to examine these potentially revolutionary biotechnologies and the emerging social, and bioethical perspectives advanced by both proponents and opponents—in the context of the legal and regulatory policies impacting ARTs and RGBs. Lastly, the paper recommends new public policy and regulatory frameworks to support future research and development of RGBs by providing legislative guidance to policymakers to ensure responsible oversight.
Recommended Citation
Girard Kelly,
Choosing the Genetics of Our Children: Options for Framing Public Policy,
30 Santa Clara High Tech. L.J. 303
(2014).
Available at: https://digitalcommons.law.scu.edu/chtlj/vol30/iss2/4
Archival Accessibility Statement
This item was created or digitized prior to May 1, 2026, or is a reproduction of legacy media created before that date. It is preserved in its original, unmodified state specifically for research, reference, or historical recordkeeping. In accordance with the ADA Title II Final Rule, the Law Library provides accessible versions of archival materials upon request. To request an accommodation for this item, please submit an accessibility request form.